J. Mulenga

P09-17. Evolution of HLA-B*5703 HIV-1 escape mutations and their impact on HIV-1 replicative capacity (2009)

Crawford, H, Lumm, W, Leslie, A, Schaefer, M, Boeras, D, Prado, J, ...

No abstract available.

P09-12. Autologous neutralizing antibodies in early subtype C HIV-1 infection target variable regions of envelope and drive multiple pathways of viral escape (2009)

Rong, R, Li, B, Haaland, RE, Murphy, MK, Mulenga, J, Allen, SA, ...

No abstract available.

P09-01. Mutation of the gp120 alpha2 helix in early subtype C HIV-1 infection fails to alter neutralization sensitivity or efficiency of in vitroreplication (2009)

Murphy, MK, Rong, R, Li, B, Mulenga, J, Allen, SA, Gnanakaran, S, ...

No abstract available.

OA06-03. Dynamics of CTL epitope escape and reversion in an African subtype C cohort (2009)

Schaefer, M, Mulenga, J, Tang, J, Goepfert, P, Farmer, P, Kaslow, R, ...

No abstract available.

Retroperitoneal Liposarcoma (2007)

Yerzingatsian, K.L., Katebe, K., Mulundika, J.I.M., Mulenga, J., Kachimba, J.S.

Liposarcoma is a rare tumor of fatty tissue. The retroperitoneal site accounts for 0.01-0.1% of all malignancies. The location makes early detection difficult and by the time the patient comes to...

OA06-03. Dynamics of CTL epitope escape and reversion in an African subtype C cohort

Schaefer, M, Mulenga, J, Tang, J, Goepfert, P, Farmer, P, Kaslow, R, ...

P09-01. Mutation of the gp120 alpha2 helix in early subtype C HIV-1 infection fails to alter neutralization sensitivity or efficiency of in vitro replication

Murphy, MK, Rong, R, Li, B, Mulenga, J, Allen, SA, Gnanakaran, S, ...

P09-12. Autologous neutralizing antibodies in early subtype C HIV-1 infection target variable regions of envelope and drive multiple pathways of viral escape

Rong, R, Li, B, Haaland, RE, Murphy, MK, Mulenga, J, Allen, SA, ...

P09-17. Evolution of HLA-B*5703 HIV-1 escape mutations and their impact on HIV-1 replicative capacity

Crawford, H, Lumm, W, Leslie, A, Schaefer, M, Boeras, D, Prado, J, ...